Purdue Pharma Appeals Ruling That Invalidated OxyContin Patents
The closely held Connecticut drug maker filed its appeal in the U.S. District Court for the Southern District of New York, stating that it would ask the U.S. Court of Appeals for the Federal Circuit to overturn the District Court's Jan. 5, 2004 ruling.
"By filing our Notice of Appeal promptly, we want to make two things...
Already a subscriber? Click here to login